{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:07Z","timestamp":1793371027497,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.08.127","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:46:37Z","timestamp":1790462797000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinical approach to psychodermatologic conditions: From recognition to treatment"],"prefix":"10.1016","author":[{"given":"Ayushya","family":"Ajmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Klufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingda","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Andres","family":"Caro Sabogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori H.","family":"Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jafferany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Shane","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.08.127_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/CCID.S111041","article-title":"Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines","volume":"10","author":"Connor","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clindermatol.2023.03.004","article-title":"Addressing body-focused repetitive behaviors in the dermatology practice","volume":"41","author":"Madan","year":"2023","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D328559260","article-title":"Dermatology urgent care model reduces costs and healthcare utilization for psychodermatology patients - a retrospective chart review","volume":"28","author":"Johnson","year":"2022","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.jaad.2026.08.127_bib4","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s13555-024-01256-3","article-title":"Exploring the intersection of body dysmorphic disorder (BDD) and dermatological conditions: a narrative review","volume":"14","author":"Li","year":"2024","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00128071-200304120-00003","article-title":"Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management","volume":"4","author":"Gupta","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib6","first-page":"4","article-title":"DSM-5 update in psychodermatology","volume":"21","author":"Nowak","year":"2016","journal-title":"Skin Ther Lett"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jdv.19731","article-title":"Classification of psychodermatological disorders: proposal of a new international classification","volume":"38","author":"Ferreira","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/ced.14157","article-title":"Diagnosis and management of psychodermatological problems: confidence levels among dermatologists and psychiatrists","volume":"45","author":"Muralidharan","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib9","article-title":"Exploring the relationship between psychiatric illness and dermatological disorders: a narrative review","volume":"17","author":"Kaye","year":"2025","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.127_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-4632.2009.04372.x","article-title":"The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study","volume":"49","author":"Jafferany","year":"2010","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib11","article-title":"Global awareness, knowledge, and practice patterns of psychocutaneous medicine: a primary care perspective","volume":"24","author":"Christensen","year":"2022","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/ipj.ipj_388_24","article-title":"Knowledge and awareness in psychodermatology: findings from a survey among Ibero-Latin American dermatologists","volume":"34","author":"Torales","year":"2025","journal-title":"Ind Psychiatry J"},{"issue":"10","key":"10.1016\/j.jaad.2026.08.127_bib13","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1111\/jocd.14917","article-title":"Psychodermatology awareness: representation of psychocutaneous diseases in dermatology textbooks","volume":"21","author":"Abduelmula","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib14","first-page":"67","article-title":"From psyche to skin: a call for interdisciplinary care in the management of psychodermatologic conditions","volume":"18","author":"Sun","year":"2025","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/12034754241311267","article-title":"Systematic review of psychodermatologic assessment tools: diagnostic accuracy and clinical utility","volume":"29","author":"Clark","year":"2025","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0378-6323.107632","article-title":"Psychodermatology: a comprehensive review","volume":"79","author":"Yadav","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2026.08.127_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0151-9638(07)92826-4","article-title":"[Stress and seborrheic dermatitis]","volume":"134","author":"Misery","year":"2007","journal-title":"Ann Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib18","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.jid.5700104","article-title":"Neuroimmunology of stress: skin takes center stage","volume":"126","author":"Arck","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000087012","article-title":"Neuroendocrine system of the skin","volume":"211","author":"Slominski","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.127_bib20","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.2741\/1966","article-title":"Corticotropin releasing hormone and the skin","volume":"11","author":"Slominski","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.jaad.2026.08.127_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2147\/CCID.S306557","article-title":"Relationship of substance P with the degree of atopic dermatitis severity","volume":"14","author":"Paramita","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00018-022-04299-x","article-title":"Cutaneous nerve fibers participate in the progression of psoriasis by linking epidermal keratinocytes and immunocytes","volume":"79","author":"Chen","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/jocd.14112","article-title":"Classification of psychodermatological disorders","volume":"20","author":"Ferreira","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/jcm13061602","article-title":"The psychology of atopic dermatitis","volume":"13","author":"Courtney","year":"2024","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038324","article-title":"Risk factors for mental illness in adults with atopic eczema or psoriasis: protocol for a systematic review","volume":"10","author":"Adesanya","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaad.2026.08.127_bib26","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.908","article-title":"Skin picking in atopic dermatitis and psoriasis patients: a single-centre cross-sectional study in China","volume":"102","author":"Ju","year":"2022","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2340\/00015555-2522","article-title":"Self-inflicted lesions in dermatology: a management and therapeuticapproach \u2013 a position paper from the European Society for Derma-tology and Psychiatry","volume":"97","author":"Tomas-Aragones","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bjd.21668","article-title":"British Association of Dermatologists guidelines for the management of adults with delusional infestation 2022","volume":"187","author":"Ahmed","year":"2022","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2340\/00015555-1506","article-title":"Self-inflicted lesions in dermatology: terminology and classification--a position paper from the European Society for Dermatology and Psychiatry (ESDaP)","volume":"93","author":"Gieler","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clindermatol.2023.02.005","article-title":"Dermatitis artefacta","volume":"41","author":"Mukundu Nagesh","year":"2023","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib31","first-page":"35","article-title":"Psychodermatology: basics concepts","volume":"96","author":"Jafferany","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0019-5154.105286","article-title":"Psychiatric evaluation in dermatology: an overview","volume":"58","author":"Ghosh","year":"2013","journal-title":"Indian J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.11.001","article-title":"Managing the patient with psychiatric issues in dermatologic practice","volume":"31","author":"Gordon-Elliott","year":"2013","journal-title":"Clin Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2026.08.127_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib35","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.2340\/00015555-3417","article-title":"\u201cDLQI seems to be \u2018action\u2019, and Skindex-29 seems to be \u2018emotion\u2019\u201d: qualitative study of the perceptions of patients with psoriasis or eczema on two common dermatology-specific quality of life measures","volume":"100","author":"Paudyal","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13969","article-title":"Management of psychocutaneous disorders: a practical approach for dermatologists","volume":"33","author":"Jafferany","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.127_bib37","article-title":"Anxiety and nonpsychotic mental disorders in acute urticaria","volume":"48","author":"Magen","year":"2025","journal-title":"Brain Behav Immun Health"},{"issue":"10","key":"10.1016\/j.jaad.2026.08.127_bib38","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.psym.2016.03.001","article-title":"Anxiety sensitivity in dermatological patients","volume":"57","author":"Dixon","year":"2016","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clindermatol.2023.03.001","article-title":"Body dysmorphic disorder: a critical appraisal of diagnostic, screening, and assessment tools","volume":"41","author":"T\u00fcrk","year":"2023","journal-title":"Clin Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.127_bib42","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jocd.15685","article-title":"Evidence-based review: screening body dysmorphic disorder in aesthetic clinical settings","volume":"22","author":"Pereira","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/ijd.70069","article-title":"The critical role of dermatologists in screening for body dysmorphic disorder","volume":"65","author":"Henke","year":"2026","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2026.08.127_bib44","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/ced\/llae204","article-title":"The prevalence of body dysmorphic disorder in outpatient dermatology clinics: a systematic review","volume":"49","author":"Saade","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.127_bib45","first-page":"545","article-title":"Appearance dissatisfaction and body dysmorphic disorder in the dermatology patient","volume":"23","author":"Sejdiu","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib46","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.6232","article-title":"Body dysmorphic disorder and self-esteem in adolescents and young adults with acne vulgaris","volume":"103","author":"Tros","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.08.127_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.genhosppsych.2016.04.001","article-title":"A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder","volume":"41","author":"Selles","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1176\/appi.psy.42.5.397","article-title":"The Skin Picking Impact Scale (SPIS): scale development and psychometric analyses","volume":"42","author":"Keuthen","year":"2001","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12622","article-title":"Trichotillomania (hair pulling disorder): clinical characteristics, psychosocial aspects, treatment approaches, and ethical considerations","volume":"32","author":"Fran\u00e7a","year":"2019","journal-title":"Dermatol Ther"},{"issue":"3-4","key":"10.1016\/j.jaad.2026.08.127_bib50","first-page":"141","article-title":"The Massachusetts General Hospital (MGH) hairpulling scale: 1. Development and factor analyses","volume":"64","author":"Keuthen","year":"1995","journal-title":"Psychother Psychosom"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib51","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/ern.11.93","article-title":"Trichotillomania and its treatment: a review and recommendations","volume":"11","author":"Franklin","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000518191","article-title":"Trichotillomania: what do we know So far?","volume":"8","author":"Melo","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaad.2026.08.127_bib53","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fpsyg.2019.01713","article-title":"Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample","volume":"10","author":"Johnson","year":"2019","journal-title":"Front Psychol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/DSS.0000000000002506","article-title":"How we do it: body dysmorphic disorder for the cosmetic dermatologist","volume":"47","author":"Sun","year":"2021","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12888-025-07236-x","article-title":"A case report of delusional parasitosis by proxy: a rare entity","volume":"25","author":"Chivily","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib56","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaad.2008.06.033","article-title":"A clinical paradigm of delusions of parasitosis","volume":"59","author":"Sandoz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/pde.14888","article-title":"Review of the diagnosis and management of pediatric psychodermatologic conditions: part I","volume":"39","author":"Mosca","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib58","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1007\/s13555-023-01053-4","article-title":"The diagnostic workup, screening, and treatment approaches for patients with delusional infestation","volume":"13","author":"Coetzee","year":"2023","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib59","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1111\/jocd.13786","article-title":"Delusional infestation: clinical presentations, diagnosis, and management","volume":"19","author":"Torales","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib60","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciae250","article-title":"State-of-the-art review: evaluation and management of delusional infestation","volume":"79","author":"Mendelsohn","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clindermatol.2023.02.004","article-title":"How to successfully handle the initial encounter with a delusional infestation patient","volume":"41","author":"Brownstone","year":"2023","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib62","doi-asserted-by":"crossref","DOI":"10.2196\/34323","article-title":"Treatments for primary delusional infestation: systematic review","volume":"5","author":"Lu","year":"2022","journal-title":"JMIR Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archdermatol.2009.20","article-title":"Treatment of delusional parasitosis with aripiprazole","volume":"145","author":"Benn\u00e0ssar","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.bp.106.029660","article-title":"Antipsychotic treatment of primary delusional parasitosis: systematic review","volume":"191","author":"Lepping","year":"2007","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpsyc.59.4.381","article-title":"A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder","volume":"59","author":"Phillips","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clindermatol.2011.11.013","article-title":"Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatrist","volume":"31","author":"Park","year":"2013","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.207","article-title":"Suicidal behaviour in psychodermatology patients: identifying characteristics and a new model for referral","volume":"3","author":"Lockwood","year":"2023","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jaad.2026.08.127_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/abn0001054","article-title":"Predicting concurrent and short-term desire and intent to attempt suicide among people with body dysmorphic disorder using ecological momentary assessment of anxiety and shame","volume":"135","author":"Weingarden","year":"2026","journal-title":"J Psychopathol Clin Sci"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-019-00621-7","article-title":"Skin-picking disorder: a guide to diagnosis and management","volume":"33","author":"Jafferany","year":"2019","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ced\/llae366","article-title":"A systematic review of nonpharmacological treatment options for skin picking disorder","volume":"50","author":"Loftus","year":"2025","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/01454455211010707","article-title":"A head-to-head comparison of three self-help techniques to reduce body-focused repetitive behaviors","volume":"46","author":"Moritz","year":"2022","journal-title":"Behav Modif"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13811","article-title":"Habit reversal therapy in the management of body focused repetitive behavior disorders","volume":"33","author":"Skurya","year":"2020","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib73","first-page":"557","article-title":"Habit reversal training for body-focused repetitive behaviors: a practical guide for the dermatologist","volume":"153","author":"Dunbar","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0974-7753.96089","article-title":"Habit reversal training for trichotillomania","volume":"4","author":"Gupta","year":"2012","journal-title":"Int J Trichology"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12888-024-05712-4","article-title":"A case report of an atypical severe case of skin picking disorder managed by a multidisciplinary team","volume":"24","author":"LeBlanc","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13385","article-title":"Psychotropic drugs in dermatology: a dermatologist's approach and choice of medications","volume":"33","author":"Jafferany","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1529-8019.2008.00172.x","article-title":"Psychopharmacology in dermatology","volume":"21","author":"Lee","year":"2008","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13073","article-title":"N-Acetylcysteine in psychodermatological disorders","volume":"32","author":"Nwankwo","year":"2019","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib79","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2016.0060","article-title":"N -Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/1516-4446-2013-1154","article-title":"N-acetylcysteine in the treatment of skin-picking disorder","volume":"36","author":"Silva-Netto","year":"2014","journal-title":"Rev Bras Psiquiatr"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.127_bib81","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib82","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2174\/1570159X17666190320164223","article-title":"Drug treatment of trichotillomania (hair-pulling disorder), excoriation (skin-picking) disorder, and nail-biting (onychophagia)","volume":"17","author":"Sani","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib83","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.psy.42.4.314","article-title":"Fluoxetine in pathologic skin-picking: open-label and double-blind results","volume":"42","author":"Bloch","year":"2001","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib84","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1468-3083.2001.00278.x","article-title":"The use of antidepressant drugs in dermatology","volume":"15","author":"Gupta","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib85","first-page":"17","article-title":"Dermatitis artefacta: a practical guide for diagnosis and management","volume":"31","author":"Torales","year":"2023","journal-title":"Acta Dermatovenerol Croat"},{"issue":"11","key":"10.1016\/j.jaad.2026.08.127_bib86","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-4632.2011.05096.x","article-title":"Psychodermatological disorders: recognition and treatment","volume":"50","author":"Shenefelt","year":"2011","journal-title":"Int J Dermatol"},{"issue":"03","key":"10.1016\/j.jaad.2026.08.127_bib87","first-page":"203","article-title":"Psychodermatology: a guide to understanding common psychocutaneous disorders","volume":"09","author":"Jafferany","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib88","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00403-025-03982-w","article-title":"Exploring the psychodermatologic burden and associated psychiatric manifestations in rosacea: a systematic review","volume":"317","author":"Sharifi","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib89","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1111\/jdv.19427","article-title":"White paper on psychodermatology in Europe: a position paper from the EADV Psychodermatology Task Force and the European Society for Dermatology and Psychiatry (ESDaP)","volume":"37","author":"Misery","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244765","article-title":"Psychosocial impact of skin diseases: a population-based study","volume":"15","author":"Yew","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YIC.0000000000000511","article-title":"Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?","volume":"39","author":"Ferrucci","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.24869\/psyd.2024.7","article-title":"Psoriasis and mental health: a psychodermatological approach with an emphasis on psychotherapy","volume":"36","author":"Krstanovi\u0107","year":"2024","journal-title":"Psychiatr Danub"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib93","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamadermatol.2023.0627","article-title":"Efficacy and safety of tralokinumab in adolescents with moderate to severe atopic dermatitis: the phase 3 ECZTRA 6 randomized clinical trial","volume":"159","author":"Paller","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib94","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(21)00588-2","article-title":"Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (measure up 1 and measure up 2): results from two replicate double-blind, randomised controlled phase 3 trials","volume":"397","author":"Guttman-Yassky","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib95","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamadermatol.2020.1406","article-title":"Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial","volume":"156","author":"Silverberg","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/pde.70127","article-title":"Society for Pediatric Dermatology 50th Annual Meeting Poster Abstracts Presented in Seattle, Washington, July 24\u201326, 2025","volume":"43","year":"2026","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib97","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12325-024-02974-y","article-title":"Improvement across dimensions of disease with lebrikizumab use in atopic dermatitis: two phase 3, randomized, double-blind, placebo-controlled monotherapy trials (ADvocate1 and ADvocate2)","volume":"42","author":"Simpson","year":"2025","journal-title":"Adv Ther"},{"issue":"17","key":"10.1016\/j.jaad.2026.08.127_bib98","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.127_bib99","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40257-024-00853-4","article-title":"Early and sustained improvements in symptoms and quality of life with upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: 52-week results from two phase III randomized clinical trials (measure up 1 and measure up 2)","volume":"25","author":"Silverberg","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib101","first-page":"36","article-title":"Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation","volume":"9","author":"Ferreira","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/ijd.14629","article-title":"Understanding psychocutaneous disease: psychosocial & psychoneuroimmunologic perspectives","volume":"59","author":"Jafferany","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1024879","article-title":"A mixed methods systematic review of digital interventions to support the psychological health and well-being of people living with dermatological conditions","volume":"9","author":"Hewitt","year":"2022","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib104","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clindermatol.2025.05.007","article-title":"The psychosocial effects of hidradenitis suppurativa","volume":"43","author":"\u0110urinec","year":"2025","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib105","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13418","article-title":"Psychodermatology of vitiligo: psychological impact and consequences","volume":"33","author":"Simons","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0019-5154.105281","article-title":"Psychological impairments in the patients with acne","volume":"58","author":"Behnam","year":"2013","journal-title":"Indian J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib107","first-page":"143","article-title":"Clinical presentations and complications of lichen sclerosus: a systematic review","volume":"23","author":"Conte","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib108","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis","volume":"155","author":"Machado","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14910","article-title":"Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa","volume":"34","author":"Akoglu","year":"2021","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib110","article-title":"Communicating with health providers and romantic partners: the impact of negative emotions on quality of life for individuals with hidradenitis suppurativa","volume":"8","author":"Ingraham","year":"2022","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/CCID.S350000","article-title":"Post-traumatic stress in vitiligo patients: a neglected but real-existing psychological impairment","volume":"15","author":"Liu","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib112","article-title":"Stigma, bullying, and resilience: psychosocial outcomes in marginalized adolescents with visible dermatologic conditions","volume":"17","author":"Parga","year":"2025","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib113","first-page":"789","article-title":"A review of patients managed at a combined psychodermatology clinic: a Singapore experience","volume":"53","author":"Chung","year":"2012","journal-title":"Singapore Med J"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijd.ijd_792_23","article-title":"Psychotropic drugs in dermatology part 1: anti-depressants and mood stabilisers","volume":"70","author":"Kenkare","year":"2025","journal-title":"Indian J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v63n0410","article-title":"Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients","volume":"63","author":"Burke","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v67n0103","article-title":"High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial","volume":"67","author":"Ninan","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2026.08.127_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115391","article-title":"Selection of the optimal dose of sertraline for depression: a dose-response meta-analysis of randomized controlled trials","volume":"327","author":"Luo","year":"2023","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.jaad.2026.08.127_bib118","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.3390\/ijerph19116370","article-title":"The potential of N-Acetylcysteine for treatment of trichotillomania, excoriation disorder, onychophagia, and onychotillomania: an updated literature review","volume":"19","author":"Lee","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/WNF.0000000000000352","article-title":"Repetitive behaviors treated with N-Acetylcysteine: case series","volume":"42","author":"Kili\u00e7","year":"2019","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clindermatol.2023.03.010","article-title":"Psychopharmacology in dermatology: five common disorders","volume":"41","author":"Ha","year":"2023","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib121","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clindermatol.2018.08.006","article-title":"Use of antipsychotic drugs in dermatology","volume":"36","author":"Gupta","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib122","series-title":"StatPearls [Internet]","first-page":"2","author":"Dhaliwal","year":"2023"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.127_bib123","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00403-024-03775-7","article-title":"Evaluating duloxetine for pruritus and psychiatric comorbidities in lichen simplex chronicus","volume":"317","author":"Shafiyev","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib124","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaad.2023.06.063","article-title":"Approach to diagnosis, evaluation, and treatment of generalized and nonlocal dysesthesia: a review","volume":"89","author":"Labib","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(86)90232-0","article-title":"Efficacy of doxepin in the treatment of chronic idiopathic urticaria","volume":"78","author":"Goldsobel","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.127_bib126","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.jaad.2026.08.127_bib127","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0149-2918(03)80320-X","article-title":"Use of gabapentin for postherpetic neuralgia: results of two randomized, placebo-controlled studies","volume":"25","author":"Stacey","year":"2003","journal-title":"Clin Ther"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib128","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib129","first-page":"378","article-title":"Gabapentin: a promising drug for the treatment of uremic pruritus","volume":"18","author":"Naini","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.jaad.2026.08.127_bib130","series-title":"Pregabalin","first-page":"2","author":"Cross","year":"2026"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N -acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jaad.2026.08.127_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.761321","article-title":"Nutrition in skin picking disorder and trichotillomania","volume":"12","author":"Grant","year":"2021","journal-title":"Front Psychiatry"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib133","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0000000000000467","article-title":"Treatment of severe excoriation disorder with mirtazapine: a case report","volume":"44","author":"Keshtkarjahromi","year":"2021","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib134","first-page":"889","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study","volume":"50","author":"Hundley","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.127_bib135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/medicines6030073","article-title":"Mirtazapine for the treatment of chronic pruritus","volume":"6","author":"Khanna","year":"2019","journal-title":"Medicines"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib136","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09546634.2019.1630702","article-title":"Defining the role of mirtazapine in the treatment of refractory pruritus","volume":"32","author":"Fawaz","year":"2021","journal-title":"J Dermatol Treat"},{"issue":"12","key":"10.1016\/j.jaad.2026.08.127_bib137","first-page":"1531","article-title":"Aripiprazole as a viable alternative for treating delusions of parasitosis","volume":"9","author":"Ladizinski","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib138","doi-asserted-by":"crossref","first-page":"126","DOI":"10.12788\/j.sder.0012","article-title":"Psychotropic medications in dermatology","volume":"32","author":"Butler","year":"2013","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.127_bib139","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ced\/llad411","article-title":"Delusional infestation treated with risperidone: a series of 27 patients","volume":"49","author":"Guedes","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib141","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/ijd.14709","article-title":"Delusional infestation: a prototype of psychodermatological disease","volume":"59","author":"Katsoulis","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.127_bib142","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230309085693","article-title":"Atypical antipsychotics in the treatment of delusional parasitosis","volume":"15","author":"Wenning","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.jaad.2026.08.127_bib143","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v105.43511","article-title":"Ethical and communicative challenges in informing patients with delusional infestation: insights from moral case deliberation","volume":"105","author":"Kemperman","year":"2025","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2026.08.127_bib144","doi-asserted-by":"crossref","first-page":"817","DOI":"10.36849\/jdd.7596","article-title":"Dermatology in contemporary times: building awareness of social media's association with adolescent skin disease and mental health","volume":"22","author":"Rieder","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.127_bib145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijwd.2018.05.002","article-title":"Implementation of a psychodermatology clinic at a major health system in Detroit","volume":"4","author":"Seale","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib146","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000539563","article-title":"Bridging the gap between dermatology and psychiatry: a review on quality of life in trichotillomania and special considerations in management","volume":"10","author":"Onyemachi","year":"2024","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.127_bib147","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaclp.2021.04.008","article-title":"Psychocutaneous medicine clinic: Wisconsin experience","volume":"62","author":"Mostaghimi","year":"2021","journal-title":"J Acad Consult liaison Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.127_bib148","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamadermatol.2020.0393","article-title":"An evidence-based approach to starting a psychodermatology clinic","volume":"156","author":"Magid","year":"2020","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:27Z","timestamp":1793370507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226036327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":148,"alternative-id":["S0190962226036327"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.127","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical approach to psychodermatologic conditions: From recognition to treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}